Cargando…
The effects of respiratory inhaled drugs on the prevention of acute mountain sickness
BACKGROUND: Acute mountain sickness (AMS) is common in high-altitude travelers, and may lead to life-threatening high-altitude cerebral edema (HACE) or high-altitude pulmonary edema (HAPE). The inhaled drugs have a much lower peak serum concentrations and a shorter half-life period than oral drugs,...
Autores principales: | Wang, Xiaomei, Chen, Hong, Li, Rong, Fu, Weiling, Yao, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133459/ https://www.ncbi.nlm.nih.gov/pubmed/30095637 http://dx.doi.org/10.1097/MD.0000000000011788 |
Ejemplares similares
-
HSPA1A gene polymorphism rs1008438 is associated with susceptibility to acute mountain sickness in Han Chinese individuals
por: Liu, Zhicheng, et al.
Publicado: (2020) -
Current prevention and management of acute mountain sickness.
por: Bia, F. J.
Publicado: (1992) -
Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study
por: Ren, Xuewen, et al.
Publicado: (2015) -
Mountain-Sickness
Publicado: (1903) -
Efficacy and safety of inhaled budesonide on prevention of acute mountain sickness during emergent ascent: a meta-analysis of randomized controlled trials
por: Nepal, Gaurav, et al.
Publicado: (2020)